Publications by authors named "Lazzaro Mazzoni"

11Publications

Identification with MRI of the pleura as a major site of the acute inflammatory effects induced by ovalbumin and endotoxin challenge in the airways of the rat.

Am J Physiol Lung Cell Mol Physiol 2006 Oct 25;291(4):L651-7. Epub 2006 May 25.

Novartis Institutes for BioMedical Research, Discovery Technologies, Lichtstr. 35, WSJ-386.2.09, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
October 2006

New highly potent and selective adenosine A(3) receptor antagonists.

Curr Top Med Chem 2004 ;4(8):863-70

Respiratory Disease Area, Novartis Horsham Research Center, Wimblehurst Road, Horsham, West Sussex, RH12 5AB, UK.

View Article and Find Full Text PDF
October 2004

Techniques: magnetic resonance imaging of the lung provides potential for non-invasive preclinical evaluation of drugs.

Trends Pharmacol Sci 2003 Oct;24(10):550-4

Discovery Technologies Center, Novartis Institutes for BioMedical Research, Lichtstrasse 35, WSJ-386.2.09, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
October 2003

Resolution of the oedema associated with allergic pulmonary inflammation in rats assessed noninvasively by magnetic resonance imaging.

Br J Pharmacol 2003 Sep 18;140(2):239-46. Epub 2003 Aug 18.

Novartis Institutes for Biomedical Research, Central Technologies, Analytics and Imaging Sciences Unit, Lichtstr. 35, WSJ-386.2.09 CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
September 2003

Effects of immunomodulators on airways hyperresponsiveness to adenosine induced in actively sensitised Brown Norway rats by exposure to allergen.

Naunyn Schmiedebergs Arch Pharmacol 2003 Jul 24;368(1):17-25. Epub 2003 Jun 24.

Novartis Institute for Biomedical Research, WSJ.386.508, 4002 Basel, Switzerland.

View Article and Find Full Text PDF
July 2003

Noninvasive detection of endotoxin-induced mucus hypersecretion in rat lung by MRI.

Am J Physiol Lung Cell Mol Physiol 2002 Jul;283(1):L22-30

Central Technologies, Novartis Pharma, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
July 2002

Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat.

Eur J Pharmacol 2002 Mar;438(3):183-8

Research Department, Novartis Pharma AG, WSJ-386.510, CH-4002, Basel, Switzerland.

View Article and Find Full Text PDF
March 2002

KCO912: a potent and selective opener of ATP-dependent potassium (K(ATP)) channels which suppresses airways hyperreactivity at doses devoid of cardiovascular effects.

Naunyn Schmiedebergs Arch Pharmacol 2002 Mar 23;365(3):220-30. Epub 2002 Jan 23.

Present address: EDQM, Council of Europe, B.P. 907, 67029 Strasbourg Cedex 1, France.

View Article and Find Full Text PDF
March 2002